Privatizing Jerusalem or an Investigation into the City\u27s Future Legal Stakes

The purpose of this article is not to propose yet another normative version for Jerusalem\u27s future. Instead, I map out the major sovereignty-related issues that have traditionally preoccupied the literature on the subject, and argue that most of these issues have become moot following the latest rounds of Israeli-Palestinian negotiations. In response to this recent paradigm shift, I propose that international law scholarship should turn its attention to studying the politics of Jerusalem\u27s private sphere, a sphere so far dismissed as merely technical , yet also a sphere replete with such deep distributional stakes as to make it the primary arena for playing out power-relations in the city\u27s future. I conclude with critiquing recent proposals that privatization would play a constructive role in defusing political tensions associated with the future Jerusalem

Ocean Wave Energy Converters: Analysis, Modeling, and Simulation. Some case studies

Wave energy has much more potential and benefits than other forms of renewable energy. It is more predictable, consistent, and controllable than wind or solar energy. In this way, an adequate infrastructure can be an alternative and also sustainable system for power supply. In this paper, different wave energy conversion mechanisms (buoys, Pelamis, and oysters) have been described. These models are implemented and simulated using the Design Modeller, ANSYS-AQWA, and WEC-SIM applications. The purpose has been to develop a complete simulation of the wave energy converter and discuss its operation. The analysis has been developed in Matlab-Simulink and both regular and irregular waves have been considered. For this, an approximation to the linear waves theory has been used. The results obtained indicate the energy absorbed from the sea waves and also the energy supplied to the power grid. The simulation results estimated with the different WEC models are comparable to the results shown by other research papers. © 2022, European Association for the Development of Renewable Energy, Environment and Power Quality (EA4EPQ). All rights reserved

Comparative Law: Problems and Prospects

This is an edited transcript of the closing plenary session of the XVIIIth International Congress of Comparative Law. The session took place on Saturday, July 31, 2010, in Washington, D.C., at the conclusion of the week-long congress, which is held quadrennially by the International Academy of Comparative Law (Acadimie Internationale de Droit Compare). The remarks were given in a mix of French and English, but for ease of reading the transcript is almost entirely in English

Comparative Law: Problems and Prospects

This is an edited transcript of the closing plenary session of the XVIIIth International Congress of Comparative Law. The session took place on Saturday, July 31, 2010, in Washington, D.C., at the conclusion of the week-long congress, which is held quadrennially by the International Academy of Comparative Law (Acadimie Internationale de Droit Compare). The remarks were given in a mix of French and English, but for ease of reading the transcript is almost entirely in English

KLK10 exon 3 unmethylated PCR product concentration: a new potential early diagnostic marker in ovarian cancer? - A pilot study

Abstract Background KLK10 exon 3 hypermethylation correlated to tumor-specific lack of KLK10 expression in cancer cell lines and primary tumors. In the present study we investigate the possible role of KLK10 exon 3 methylation in ovarian tumor diagnosis and prognosis. Results Qualitative methylation-specific PCR (MSP) results did not show statistically significant differences in patient group samples (normal and tumor) where all samples were positive only for the unmethylated-specific PCR except for two malignant samples that were either doubly positive (serous carcinoma) or doubly negative (Sertoli-Leydig cell tumor) for the two MSP tests. However, KLK10 exon 3 unmethylated PCR product concentration (ng/μl) showed statistically significant differences in benign and malignant patient group samples; mean ± SD (n): tumor: 0.077 ± 0.035 (14) and 0.047 ± 0.021 (15), respectively, p-value = 0.011; and normal: 0.094 ± 0.039 (7) and 0.046 ± 0.027 (6), respectively, p-value = 0.031. Moreover, ROC curve analysis of KLK10 exon 3 unmethylated PCR product concentration in overall patient group samples showed good diagnostic ability (AUC = 0.778; p-value = 0.002). Patient survival (living and died) showed statistically significant difference according to preoperative serum CA125 concentration (U/ml); median (n): 101.25 (10) and 1252 (5), respectively, p-value = 0.037, but not KLK10 exon 3 unmethylated PCR product concentration (ng/μl) in overall malignant patient samples; mean ± SD (n): 0.042 ± 0.015 (14) and 0.055 ± 0.032 (7), p-value = 0.228. Conclusion To the best of our knowledge, this is the first report on KLK10 exon 3 unmethylated PCR product concentration as potential early epigenetic diagnostic marker in primary ovarian tumors. Taken into account the limitations in our study (small sample size and semi-quantitative PCR product analysis) further studies are strongly recommended